Hargreaves' shrinking buy list
Loading player...
Citywire editors Gavin Lumsden and Daniel Grote discuss Hargreaves Lansdown's revamp of its fund buy list and whether Fundsmith could finally make an entry.
Other recent episodes
Seraphim’s Boggett ‘unapologetic’ about near-40% ICEYE holding
Seraphim Space CEO Market Boggett defends largest holding and shares fresh deployment plans after £137m raise.
Allianz Tech: Wave of trillion-dollar IPOs could dethrone tech leaders
Investors could fund the highly anticipated listings of SpaceX and Anthropic – plus the numerous others on the horizon – by selling the Magnificent Seven giants that have long dominated markets.
Luke Finch: AI progress is a ‘win win’ for HgCapital
Head of Client Services at European and US software investor Hg, manager of HgCapital, defends the sector against rapid AI advancement.
Nick Train: Worse-ification is the route to mediocrity
The Lindsell Train manager defends his high-conviction approach that has been ‘wonderful on the upside but painful on the downside’. Despite falling far behind the benchmark in recent years, Train said that ‘in a world of ETFs and index huggers, it is necessary to offer investors a strategy that is…
We're 'in the early innings' of a biotech recovery
RTW’s Oliver Kenyon unpacks the biotech opportunity as pioneering companies move into commercialisation, and explains why he thinks the sector still looks attractively valued.